Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients
Tài liệu tham khảo
Tonelli, 2006, Chronic kidney disease and mortality risk: a systematic review, J Am Soc Nephrol, 17, 2034, 10.1681/ASN.2005101085
Kendrick, 2008, Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease, Nat Clin Pract Nephrol, 4, 672, 10.1038/ncpneph0954
Libetta, 2011, Oxidative stress and inflammation: implications in uremia and hemodialysis, Clin Biochem, 44, 1189, 10.1016/j.clinbiochem.2011.06.988
Choi, 2012, The malnutrition-inflammation-depression-arteriosclerosis complex is associated with an increased risk of cardiovascular disease and all-cause death in chronic hemodialysis patients, Nephron Clin Pract, 122, 44, 10.1159/000348509
Akchurin, 2015, Update on inflammation in chronic kidney disease, Blood Purif, 39, 84, 10.1159/000368940
Kooman, 2017, Inflammation and premature aging in advanced chronic kidney disease, Am J Physiol Renal Physiol, 313, F938, 10.1152/ajprenal.00256.2017
Stenvinkel, 2005, IL-10, IL-6, and TNFalpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly, Kidney Int, 67, 1216, 10.1111/j.1523-1755.2005.00200.x
Cook, 2004, Toll-like receptors in the pathogenesis of human disease, Nat Immunol, 5, 975, 10.1038/ni1116
Beutler, 2009, TLRs and innate immunity, Blood, 113, 1399, 10.1182/blood-2008-07-019307
Kawasaki, 2014, Toll-like receptor signaling pathways, Front Immunol, 5, 461, 10.3389/fimmu.2014.00461
Rosadini, 2017, Early innate immune responses to bacterial LPS, Curr Opin Immunol, 44, 14, 10.1016/j.coi.2016.10.005
Jaresova, 2007, Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis, Microbes Infect, 9, 1359, 10.1016/j.micinf.2007.06.009
Iwami, 2000, Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling, J Immunol, 165, 6682, 10.4049/jimmunol.165.12.6682
Zunt, 2009, Soluble forms of Toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells, Clin Exp Immunol, 156, 285, 10.1111/j.1365-2249.2009.03854.x
Ten Oever, 2014, The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases, BMC Immunol, 15, 55, 10.1186/s12865-014-0055-y
Martin-Rodriguez, 2015, TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia, Eur J Clin Invest, 45, 160, 10.1111/eci.12392
Koc, 2011, Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation, Nephrol Dial Transpl, 26, 955, 10.1093/ndt/gfq500
Mudaliar, 2014, Role of Toll-like receptors in diabetic nephropathy, Clin Sci (Lond), 126, 685, 10.1042/CS20130267
Anderberg, 2017, Physiological aspects of Toll-like receptor 4 activation in sepsis-induced acute kidney injury, Acta Physiol (Oxf), 219, 573, 10.1111/apha.12798
Verzola, 2017, Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease, J Cachexia Sarcopenia Muscle, 8, 131, 10.1002/jcsm.12129
Broers, 2015, Body composition in dialysis patients: a functional assessment of bioimpedance using different prediction models, J Ren Nutr, 25, 121, 10.1053/j.jrn.2014.08.007
Korevaar, 2004, Effect of an increase in C-reactive protein level during a hemodialysis session on mortality, J Am Soc Nephrol, 15, 2916, 10.1097/01.ASN.0000143744.72664.66
Herselman, 2010, Relationship between body mass index and mortality in adults on maintenance hemodialysis: a systematic review, J Ren Nutr, 20, 281, 10.1053/j.jrn.2010.03.010
Ikizler, 2008, Nutrition, inflammation and chronic kidney disease, Curr Opin Nephrol Hypertens, 17, 162, 10.1097/MNH.0b013e3282f5dbce
Memoli, 2007, Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor, Am J Physiol Endocrinol Metab, 293, E1030, 10.1152/ajpendo.00697.2006
Han, 2011, Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis, Clin Endocrinol (Oxf), 75, 857, 10.1111/j.1365-2265.2011.04120.x
Rao, 2005, Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients, Am J Kidney Dis, 45, 324, 10.1053/j.ajkd.2004.09.018
Fukasawa, 2017, Lower thigh muscle mass is associated with all-cause and cardiovascular mortality in elderly hemodialysis patients, Eur J Clin Nutr, 71, 64, 10.1038/ejcn.2016.186
Meert, 2009, Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial, Nephrol Dial Transplant, 24, 562, 10.1093/ndt/gfn522
Lin, 2002, Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration, Blood Purif, 20, 349, 10.1159/000063103
Knezevic, 2012, Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients, Ren Fail, 34, 849, 10.3109/0886022X.2012.684555
Davenport, 2016, Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size, Kidney Int, 89, 193, 10.1038/ki.2015.264
Leurs, 2013, Effects of hemodiafiltration on uremic inflammation, Blood Purif, 35 Suppl 1, 11, 10.1159/000346359
Esposito, 2017, Modulation of Myostatin/Hepatocyte Growth Factor balance by different hemodialysis modalities, Biomed Res Int, 2017, 7635459
Liew, 2005, Negative regulation of toll-like receptor-mediated immune responses, Nat Rev Immunol, 5, 446, 10.1038/nri1630
Hyakushima, 2004, Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling, J Immunol, 173, 6949, 10.4049/jimmunol.173.11.6949
Memoli, 2005, In vivo modulation of soluble “antagonistic” IL-6 receptor synthesis and release in ESRD, J Am Soc Nephrol, 16, 1099, 10.1681/ASN.2004080628
Esposito, 2012, Soluble CD40 as a modulator of CD40 pathway, Immunol Lett, 147, 85, 10.1016/j.imlet.2012.06.003
Mulay, 2016, Necroinflammation in kidney disease, J Am Soc Nephrol, 27, 27, 10.1681/ASN.2015040405
Santoni, 2015, Toll like receptors and pancreatic diseases: from a pathogenetic mechanism to a therapeutic target, Cancer Treat Rev, 41, 569, 10.1016/j.ctrv.2015.04.004
Jia, 2014, TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease, Int Immunopharmacol, 23, 54, 10.1016/j.intimp.2014.08.011
Liu, 2014, Protective effect of resveratrol against IL-1beta-induced inflammatory response on human osteoarthritic chondrocytes partly via the TLR4/MyD88/NFkappaB signaling pathway: an “in vitro study”, Int J Mol Sci, 15, 6925, 10.3390/ijms15046925
Souza, 2015, TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression, Physiol Rep, 3, e12558, 10.14814/phy2.12558
Peri, 2014, Toll-like Receptor 4 (TLR4) modulation by synthetic and natural compounds: an update, J Med Chem, 57, 3612, 10.1021/jm401006s